Citadel Advisors
CYRX icon

Citadel Advisors’s CryoPort CYRX Stock Holding History

Citadel Advisors’s Portfolio CYRX Stock Details CYRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.52M Sell
183,178
-49,182
-21% -$444K ﹤0.01% 6684
2025
Q4 		$2.23M Sell
232,360
-156,230
-40% -$1.48M ﹤0.01% 5704
2025
Q3 		$3.68M Buy
388,590
+266,532
+218% +$2.24M ﹤0.01% 4919
2025
Q2 		$911K Sell
122,058
-86,524
-41% -$537K ﹤0.01% 7317
2025
Q1 		$1.27M Buy
208,582
+113,231
+119% +$783K ﹤0.01% 6424
2024
Q4 		$742K Buy
95,351
+30,317
+47% +$226K ﹤0.01% 7666
2024
Q3 		$527K Sell
65,034
-233,503
-78% -$1.91M ﹤0.01% 8152
2024
Q2 		$2.06M Buy
298,537
+142,768
+92% +$1.92M ﹤0.01% 5238
2024
Q1 		$2.76M Sell
155,769
-100,490
-39% -$1.59M ﹤0.01% 4932
2023
Q4 		$3.97M Sell
256,259
-333,249
-57% -$4.35M ﹤0.01% 4140
2023
Q3 		$8.08M Buy
589,508
+79,631
+16% +$1.17M ﹤0.01% 2952
2023
Q2 		$8.8M Buy
509,877
+361,249
+243% +$7.39M ﹤0.01% 2845
2023
Q1 		$3.57M Sell
148,628
-103,008
-41% -$2.24M ﹤0.01% 4367
2022
Q4 		$4.37M Buy
251,636
+32,747
+15% +$690K ﹤0.01% 4084
2022
Q3 		$5.33M Buy
+218,889
New +$7.53M ﹤0.01% 3757
2022
Q2 		– Sell
-46,601
Closed -$1.24M – 13040
2022
Q1 		$1.63M Sell
46,601
-23,049
-33% -$871K ﹤0.01% 6550
2021
Q4 		$4.12M Buy
69,650
+12,429
+22% +$860K ﹤0.01% 4680
2021
Q3 		$3.81M Sell
57,221
-111,964
-66% -$6.9M ﹤0.01% 4856
2021
Q2 		$10.7M Sell
169,185
-74,983
-31% -$4.22M ﹤0.01% 2973
2021
Q1 		$12.7M Buy
244,168
+98,412
+68% +$5.98M ﹤0.01% 2616
2020
Q4 		$6.4M Sell
145,756
-102,839
-41% -$4.9M ﹤0.01% 3264
2020
Q3 		$11.8M Buy
248,595
+149,256
+150% +$6.04M ﹤0.01% 2095
2020
Q2 		$3M Sell
99,339
-127,321
-56% -$2.83M ﹤0.01% 3867
2020
Q1 		$3.87M Sell
226,660
-92,085
-29% -$1.61M ﹤0.01% 3082
2019
Q4 		$5.25M Buy
318,745
+28,316
+10% +$421K ﹤0.01% 3019
2019
Q3 		$4.75M Buy
+290,429
New +$5.82M ﹤0.01% 3176
2018
Q3 		– Sell
-19,445
Closed -$307K – 9271
2018
Q2 		$307K Buy
+19,445
New +$207K ﹤0.01% 7172

Other funds holding CYRX

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return

Citadel Advisors's CYRX Position: Q1 2026 in Review

Citadel Advisors reduced its CryoPort (CYRX) stake by 21% in Q1 2026, selling an estimated $444K and leaving 183,178 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #6684.

Citadel Advisors first reported a position in CYRX in Q2 2018 and has held it in 27 quarters since. The position peaked at $12.7M in Q1 2021. 165 funds tracked by Wall St. Rank hold CYRX as of Q1 2026.

  • Citadel Advisors held 183,178 shares of CryoPort worth $1.52M as of Q1 2026.
  • Citadel Advisors sold 49,182 CryoPort shares in Q1 2026, an estimated $444K.
  • CryoPort made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6684 holding.
  • Citadel Advisors first reported a position in CryoPort in Q2 2018 and has held it in 27 quarters since.
  • Citadel Advisors's CryoPort position peaked at $12.7M in Q1 2021.
  • 165 funds tracked by Wall St. Rank held CryoPort as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.